MUTUAL NON-DISCLOSURE AGREEMENT

SAMPLE DOCUMENT — fictional, written by AbrahamMoses for demonstration. The parties and terms are invented.

This Mutual Non-Disclosure Agreement is entered into on 15 May 2026 between Lindqvist Biotech AB, a company registered in Sweden (the "Discloser"), and Orrin Capital Partners LLP, a limited liability partnership registered in England (the "Recipient"). The Discloser and the Recipient may each disclose and receive information under this Agreement.

1. Purpose
The parties wish to evaluate a possible investment by the Recipient in the Discloser (the "Purpose") and will exchange confidential information for that Purpose only.

2. Confidential Information
"Confidential Information" means all information disclosed by one party to the other in connection with the Purpose, whether written or oral, including business plans, clinical data, financial forecasts and know-how. Confidential Information does not include information that (a) is or becomes public other than through a breach of this Agreement, (b) was lawfully known to the receiving party before disclosure, or (c) is independently developed by the receiving party.

3. Obligations
3.1 The receiving party shall keep the Confidential Information strictly confidential and shall not disclose it to any third party without the prior written consent of the disclosing party.
3.2 The receiving party may disclose Confidential Information to its directors, employees and professional advisers who need to know it for the Purpose and are bound by obligations of confidentiality no less strict than these.
3.3 The Recipient shall not use the Confidential Information to make any investment in a competitor of the Discloser.
3.4 The Recipient shall not, for a period of two (2) years from the date of this Agreement, solicit or employ any employee of the Discloser.

4. Term
4.1 This Agreement applies to information disclosed during a period of twelve (12) months from the date of this Agreement.
4.2 The confidentiality obligations in this Agreement shall survive indefinitely.

5. Return of Information
On written request, the receiving party shall return or destroy all Confidential Information within ten (10) Business Days, except copies it must keep by law.

6. Remedies
Each party acknowledges that damages may not be an adequate remedy for a breach and that the other party may seek injunctive relief. A party that breaches this Agreement shall pay liquidated damages of EUR 250,000 for each breach.

7. Governing Law
This Agreement shall be governed by the laws of England and Wales.

8. Jurisdiction
The parties submit to the exclusive jurisdiction of the courts of Sweden. This Agreement shall be governed by the laws of Sweden.